Theriva Biologics, Inc. (TOVX)
0.24
0.00 (0.00%)
USD |
NYAM |
Aug 24, 16:00
0.24
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics Max Drawdown (5Y) : 99.94% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 99.94% |
| June 30, 2026 | 99.94% |
| May 31, 2026 | 99.94% |
| April 30, 2026 | 99.94% |
| March 31, 2026 | 99.94% |
| February 28, 2026 | 99.94% |
| January 31, 2026 | 99.94% |
| December 31, 2025 | 99.94% |
| November 30, 2025 | 99.93% |
| October 31, 2025 | 99.90% |
| September 30, 2025 | 99.87% |
| August 31, 2025 | 99.87% |
| July 31, 2025 | 99.85% |
| June 30, 2025 | 99.85% |
| May 31, 2025 | 99.85% |
| April 30, 2025 | 99.64% |
| March 31, 2025 | 99.62% |
| February 28, 2025 | 99.61% |
| January 31, 2025 | 99.61% |
| December 31, 2024 | 99.61% |
| November 30, 2024 | 99.58% |
| October 31, 2024 | 99.58% |
| September 30, 2024 | 99.53% |
| August 31, 2024 | 98.89% |
| July 31, 2024 | 98.75% |
| Date | Value |
|---|---|
| June 30, 2024 | 98.75% |
| May 31, 2024 | 98.75% |
| April 30, 2024 | 98.75% |
| March 31, 2024 | 98.75% |
| February 29, 2024 | 99.92% |
| January 31, 2024 | 99.93% |
| December 31, 2023 | 99.93% |
| November 30, 2023 | 99.94% |
| October 31, 2023 | 99.94% |
| September 30, 2023 | 99.94% |
| August 31, 2023 | 99.94% |
| July 31, 2023 | 99.94% |
| June 30, 2023 | 99.94% |
| May 31, 2023 | 99.94% |
| April 30, 2023 | 99.94% |
| March 31, 2023 | 99.94% |
| February 28, 2023 | 99.94% |
| January 31, 2023 | 99.94% |
| December 31, 2022 | 99.94% |
| November 30, 2022 | 99.94% |
| October 31, 2022 | 99.94% |
| September 30, 2022 | 99.94% |
| August 31, 2022 | 99.94% |
| July 31, 2022 | 99.94% |
| June 30, 2022 | 99.94% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 96.33% |
| Nkarta, Inc. | 98.27% |
| Unicycive Therapeutics, Inc. | 95.97% |
| OnKure Therapeutics, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -86.23 |
| Beta (5Y) | 1.108 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 89.08% |
| Historical Sharpe Ratio (5Y) | -0.8535 |
| Historical Sortino (5Y) | -1.501 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 40.41% |